The pharmacy spend increases health systems can expect.
Oncologists are under intense pressure to come up with cost savings—and many are turning to value-based care structures.
A judge has put a halt to President Trump’s requirement for drug prices in television ads.
Managed Healthcare Executive’s Managed Care Pharmacy Survey identifies different ways specialty pharmacy stakeholders believe they can reduce industry costs moving forward.
How will payers, providers, and patients respond when a $2 million drug drops into the market?
With a more than $2 million price tag, how are payers going to deal with the recently approved Zolgensma?
Where plans and patients are spending the most money on medications.
The United States pays much higher drug prices than other countries. Could reference pricing be the fix?
Drug costs are a hot political topic, but just how much do they disrupt healthcare?
What health execs need to know about the drugs and policies affecting spending.